Saturday, Mar 25, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | India | 375000 Vials Of Amphotericin B To Be Allocated To States Uts

3,75,000 vials of Amphotericin-B to be allocated to states, UTs

Given the sudden surge in the demand for Amphotericin-B which is being prescribed for patients suffering from mucormycosis, the Union government while remaining engaged with the drug manufacturers has decided to make allocation

By Telangana Today
Updated On - 03:15 PM, Thu - 17 June 21
3,75,000 vials of Amphotericin-B to be allocated to states, UTs

Hyderabad: The domestic production capacity of Amphotericin B Liposomal Injection, prescribed for patients suffering from mucormycosis, has registered a five-fold increase in a short span time, going up from about 62,000 in April to 1.63 lakh vials in May and is expected to cross 3.75 lakh vials in June.

Given the sudden surge in the demand for Amphotericin-B which is being prescribed for patients suffering from mucormycosis, the Union government while remaining engaged with the drug manufacturers has decided to make allocation of the limited stocks among the states.

The existing five manufacturers of Liposomal Amphotericin-B — Bharat Serums and Vaccines Limited, Cipla, Sun Pharma, BDR Pharmaceuticals and Lifecare Innovations — are expected to release about 2.63 lakh vials for the month of June.

The DCGI, has also issued manufacturing/marketing permission of Amphotericin B Liposomal Injection to six firms — Emcure, Gufic, Alembic, Lyka, Natco Limited and Intas Pharma. The expected release by the six new manufacturers for the month of June is about 1.13 lakh vials.

Through active measures to augment production, and import and ensure equitable distribution, the government has been able to mobilise over 6.67 lakh vials of the Amphotericin-B for patients in the states and UTs and Central Health Institutes, in addition to other drugs such as Amphotericin Deoxycholate and Posaconazole being used for treatment of this disease.

Import facilitation:

The Ministry of External Affairs (MEA) through its missions all over the world, has identified new sources of Amphotericin B/ Liposomal Amphotericin B injections and alternative drugs for treatment of mucormycosis. Out of the identified sources, the steps were initiated to procure Liposomal Amphotericin-B from Australia, Russia, Germany, Argentina, Belgium and China.

Department of Pharmaceuticals and the Indian Embassy in the USA are working with Mylan Labs for increasing import and ensuring early delivery from Gilead Inc. USA. Out of total orders placed with Gilead for 9,05,000 vials, the stocks of 5,33,971 vials have already been received till June 16 and the remaining deliveries are being expedited.

Making allocation:

To ensure equitable distribution of the limited stocks, the government decided to make allocation of limited stocks among states and ensure all states with patients of mucormycosis get a fair chance of accessing a share of the supplies. Allotments are being made to the States/ UTs in accordance with the proportion of their reported case load in respect of the entire country. The number of patients in a particular State is derived from the portal of Ministry of Health and Family Welfare, in which the States themselves enter the figures of patient load in their respective states. This allocation regime is an interim arrangement till the supply of the drug stabilises vis a vis the demand.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

  • Follow Us :
  • Tags
  • Amphotericin B Liposomal Injection
  • Domestic production
  • Hyderabad
  • Mucormycosis

Related News

  • Hyderabad-based firm comes up with cost-effective STPs

    Hyderabad-based firm comes up with cost-effective STPs

  • Hyderabad: Koheda market works to kickstart soon

    Hyderabad: Koheda market works to kickstart soon

  • Hyderabad: 5th ISSE national conference organized

    Hyderabad: 5th ISSE national conference organized

  • Rare celestial event occurs in Hyderabad; Moon, Venus align in conjunction

    Rare celestial event occurs in Hyderabad; Moon, Venus align in conjunction

  • Mines Safety Dept sanctions first aid training center in Hyderabad

    Mines Safety Dept sanctions first aid training center in Hyderabad

  • TSPSC paper leak: Twelve arrested, 19 witnesses examined by SIT

    TSPSC paper leak: Twelve arrested, 19 witnesses examined by SIT

Latest News

  • Dasara movie bookings are open on BookMyShow and Paytm

    5 mins ago
  • To check illegal activities Gujarat police conduct raids at 17 jails in state

    20 mins ago
  • Disqualification of Rahul goes against basic tenets of Constitution: Sharad Pawar

    34 mins ago
  • Paytm launches upgraded payments platform powered by fully indigenous technology

    59 mins ago
  • Delhi: Man arrested for killing male friend, having unnatural sex with corpse

    1 hour ago
  • XBB 1.16 variant not severe, say public health experts

    2 hours ago
  • Trump arrested? Fake AI images flood internet

    2 hours ago
  • Telangana HC permits BJP protest at Dharna Chowk

    2 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam